F11R and atherosclerosis: Complementary findings revealed that genetic deletion of JAM-A in atherosclerosis-prone apoE−/− mice reduced neointimal hyperplasia, decreased neointimal macrophage content, and impaired the adhesion of monocytes to ex vivo perfused carotid arteries [25].